Article
Published 9 Oct 2025
汉坤 • 观点 | 医药BD项目如何友好"分手"？
Han Kun Law Offices
Your search returned 225 results
Refine Your Search
Search Results
- Relevance
- Newest
- Oldest
Article
Published 9 Oct 2025
How Digital Therapeutics (DTx) Products Are Regulated In China?
Han Kun Law Offices
Article
Published 9 Oct 2025
2024 Data Analytics: China Life Sciences NewCo & Licensing Terms
Han Kun Law Offices
Article
Published 7 Oct 2025
Han Kun • Opinion | The New Ethical Review Regulations Focus On Quick Comments
Han Kun Law Offices
Article
Published 7 Oct 2025
Han Kun • Opinion | Hainan Boao Lecheng Clinical Urgently Needs A Review Of The Highlights Of The New Regulations On The Management Of Imported Drugs And Devices
Han Kun Law Offices
Article
Published 6 Oct 2025
Han Kun • Opinion | Brief Review Of The Measures For The Review Of Science And Technology Ethics (Trial) (Draft For Comments)
Han Kun Law Offices
Article
Published 3 Oct 2025
汉坤 • 观点 | CAR-T/NK监管路在何方 — 体细胞临床研究工作指引（征求意见稿）要点解读
Han Kun Law Offices
Article
Published 3 Oct 2025
Han Kun • Opinion | Implementation And Regulation Of DCT (Decentralized Clinical Trials) In China
Han Kun Law Offices
Article
Published 3 Oct 2025
汉坤 • 观点 | LDT试点新规解读
Han Kun Law Offices
Article
Published 2 Oct 2025
Han Kun • Opinion | The Spring Of Traditional Chinese Medicine? From The "Special Provisions On The Registration And Administration Of Traditional Chinese Medicines", The Characteristic Marketing Evaluation System Of Traditional Chinese Medicine
Han Kun Law Offices
Article
Published 1 Oct 2025
药企出海新热点：管线分拆"SON"模式的实践解读
Han Kun Law Offices
Article
Published 1 Oct 2025
Han Kun Opinion | Breaking News: 10 Questions And Answers On Pharmaceutical Anti-Corruption In 2023
Han Kun Law Offices
Article
Published 1 Oct 2025
Han Kun Opinion | CAR-T/NK Regulatory Decisions — Interpreting The "Guidelines For Somatic Cell Clinical Research (Trial)"
Han Kun Law Offices
Article
Published 29 Sep 2025
汉坤 • 观点 | 从药械产品全生命周期视角解读License-in/out许可交易项目合作条款要点
Han Kun Law Offices
Article
Published 29 Sep 2025
汉坤 • 观点 | 企业或需自设伦理委员会：《科技伦理审查办法（试行）》正式出台
Han Kun Law Offices
Article
Published 29 Sep 2025
Han Kun • Opinion | Interpret The New Regulations For The Inspection Of Drug Clinical Trial Institutions In The Post-"722 Storm" Era
Han Kun Law Offices
Article
Published 29 Sep 2025
Han Kun • Opinion | 2023 Life Sciences Regulatory Compliance Annual Summary
Han Kun Law Offices
Article
Published 29 Sep 2025
Han Kun • Opinion | Quick Review Of The New Regulations: Interpret The Latest Questions And Answers Of The Ministry Of Science And Technology
Han Kun Law Offices
Article
Published 25 Sep 2025
Han Kun • Quick Comment | Is The Transmission Of Cross-border Genomic Data Between China And The United States Blocked? Biden Data Executive Order Quick Review
Han Kun Law Offices
Article
Published 25 Sep 2025
Han Kun • Opinion | Analysis Of Key Points Of License-In/out Contract Disputes In The Life Sciences Industry (1): Joint Steering Committee, Reasonable Commercial Efforts, Confidentiality Obligations
Han Kun Law Offices